GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VioQuest Pharmaceuticals Inc (OTCPK:VOQP) » Definitions » Total Assets

VioQuest Pharmaceuticals (VioQuest Pharmaceuticals) Total Assets : $1.18 Mil (As of Jun. 2008)


View and export this data going back to . Start your Free Trial

What is VioQuest Pharmaceuticals Total Assets?

VioQuest Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2008 was $1.18 Mil.

Total Assets is connected with ROA %. VioQuest Pharmaceuticals's annualized ROA % for the quarter that ended in Jun. 2008 was -482.56%. Total Assets is also linked to Revenue through Asset Turnover. VioQuest Pharmaceuticals's Asset Turnover for the quarter that ended in Jun. 2008 was 0.00.


VioQuest Pharmaceuticals Total Assets Historical Data

The historical data trend for VioQuest Pharmaceuticals's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VioQuest Pharmaceuticals Total Assets Chart

VioQuest Pharmaceuticals Annual Data
Trend Dec98 Dec99 Dec00 Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.59 4.88 8.38 5.83 1.36

VioQuest Pharmaceuticals Quarterly Data
Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.69 3.46 1.36 0.70 1.18

VioQuest Pharmaceuticals Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

VioQuest Pharmaceuticals's Total Assets for the fiscal year that ended in Dec. 2007 is calculated as

Total Assets=Total Equity (A: Dec. 2007 )+Total Liabilities (A: Dec. 2007 )
=-4.484+5.843
=1.36

VioQuest Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2008 is calculated as

Total Assets=Total Equity (Q: Jun. 2008 )+Total Liabilities (Q: Jun. 2008 )
=-5.671+6.848
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


VioQuest Pharmaceuticals  (OTCPK:VOQP) Total Assets Explanation

Total Assets is connected with ROA %.

VioQuest Pharmaceuticals's annualized ROA % for the quarter that ended in Jun. 2008 is

ROA %=Net Income (Q: Jun. 2008 )/( (Total Assets (Q: Mar. 2008 )+Total Assets (Q: Jun. 2008 ))/ count )
=-4.524/( (0.698+1.177)/ 2 )
=-4.524/0.9375
=-482.56 %

Note: The Net Income data used here is four times the quarterly (Jun. 2008) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

VioQuest Pharmaceuticals's Asset Turnover for the quarter that ended in Jun. 2008 is

Asset Turnover
=Revenue (Q: Jun. 2008 )/( (Total Assets (Q: Mar. 2008 )+Total Assets (Q: Jun. 2008 ))/ count )
=0/( (0.698+1.177)/ 2 )
=0/0.9375
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

VioQuest Pharmaceuticals Total Assets Related Terms

Thank you for viewing the detailed overview of VioQuest Pharmaceuticals's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


VioQuest Pharmaceuticals (VioQuest Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
P.O. Box 2287, Minneapolis, MN, USA, 55402
Website
VioQuest Pharmaceuticals Inc is a biopharmaceutical company focused on the acquisition, development and commercialization of clinical stage drug therapies targeting both the molecular basis of cancer and side effects of cancer treatment.
Executives
Mark D Dacko director, officer: CFO and Secretary 800 NICOLLET MALL SUITE 2690, MINNEAPOLIS MN 55402
Christopher P. Schnittker officer: V.P. & Chief Financial Officer 29 EMMONS DRIVE, SUITE C-10, PRINCETON NJ 08540
Brian Lenz officer: CFO and Treasurer 65 COMMERCE WAY, HACKENSACK NJ 07601
Lau Johnson Yiu Nam director
Michael Weiser director C/O SPACES, SUITE 265, 3350 VIRGINIA STREET, MIAMI FL 33133
Stephen Rocamboli director, officer: Secretary C/OPARMOUNT CAPITAL, 787 SEVENTH AVE 48TH FL, NEW YORK NY 10019
Daniel E Greenleaf director, officer: President and CEO C/O NABI BIO PHARMACEUTICALS, 5800 PARK OF COMMERCE BLVD., N.W., BOCA RATON FL 33487
Lester E Lipschutz 10 percent owner WOLF BLOCK SCHORR AND SOLIS COHEN, 1650 ARCH STREET, PHILADELPHIA PA 19103
David M Tanen director TWO RIVER GROUP HOLDINGS, LLC., 689 FIFTH AVENUE, NEW YORK NY 10022

VioQuest Pharmaceuticals (VioQuest Pharmaceuticals) Headlines

No Headlines